rs112803997

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004444.5(EPHB4):​c.2949G>T​(p.Pro983Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00526 in 1,575,352 control chromosomes in the GnomAD database, including 253 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P983P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 117 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 136 hom. )

Consequence

EPHB4
NM_004444.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.555

Publications

3 publications found
Variant links:
Genes affected
EPHB4 (HGNC:3395): (EPH receptor B4) Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. The protein encoded by this gene binds to ephrin-B2 and plays an essential role in vascular development. [provided by RefSeq, Jul 2008]
EPHB4 Gene-Disease associations (from GenCC):
  • capillary malformation-arteriovenous malformation 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • EPHB4-associated vascular malformation spectrum
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • lymphatic malformation 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • capillary malformation-arteriovenous malformation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 7-100803476-C-A is Benign according to our data. Variant chr7-100803476-C-A is described in ClinVar as Benign. ClinVar VariationId is 811022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.555 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0756 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004444.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPHB4
NM_004444.5
MANE Select
c.2949G>Tp.Pro983Pro
synonymous
Exon 17 of 17NP_004435.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPHB4
ENST00000358173.8
TSL:1 MANE Select
c.2949G>Tp.Pro983Pro
synonymous
Exon 17 of 17ENSP00000350896.3P54760-1
EPHB4
ENST00000360620.7
TSL:1
c.2793G>Tp.Pro931Pro
synonymous
Exon 16 of 16ENSP00000353833.3Q96L35
EPHB4
ENST00000487222.5
TSL:1
n.4150G>T
non_coding_transcript_exon
Exon 16 of 16

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3509
AN:
152170
Hom.:
115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0777
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00983
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00869
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000691
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00741
AC:
1506
AN:
203110
AF XY:
0.00656
show subpopulations
Gnomad AFR exome
AF:
0.0780
Gnomad AMR exome
AF:
0.00438
Gnomad ASJ exome
AF:
0.00246
Gnomad EAS exome
AF:
0.0000639
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000608
Gnomad OTH exome
AF:
0.00500
GnomAD4 exome
AF:
0.00335
AC:
4762
AN:
1423064
Hom.:
136
Cov.:
30
AF XY:
0.00335
AC XY:
2356
AN XY:
702568
show subpopulations
African (AFR)
AF:
0.0829
AC:
2743
AN:
33078
American (AMR)
AF:
0.00523
AC:
205
AN:
39228
Ashkenazi Jewish (ASJ)
AF:
0.00309
AC:
78
AN:
25280
East Asian (EAS)
AF:
0.0000260
AC:
1
AN:
38498
South Asian (SAS)
AF:
0.0106
AC:
862
AN:
81298
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51476
Middle Eastern (MID)
AF:
0.0121
AC:
69
AN:
5682
European-Non Finnish (NFE)
AF:
0.000362
AC:
395
AN:
1089698
Other (OTH)
AF:
0.00695
AC:
409
AN:
58826
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
211
421
632
842
1053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3524
AN:
152288
Hom.:
117
Cov.:
32
AF XY:
0.0231
AC XY:
1717
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0778
AC:
3234
AN:
41558
American (AMR)
AF:
0.00975
AC:
149
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00911
AC:
44
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000691
AC:
47
AN:
68030
Other (OTH)
AF:
0.0175
AC:
37
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
163
326
490
653
816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00816
Hom.:
18
Bravo
AF:
0.0263

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
2.6
DANN
Benign
0.65
PhyloP100
0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112803997; hg19: chr7-100401098; API